Ticker LaunchUplisting · GHSI
Guardion Health Sciences, Inc.
Formerly Guardion Health Sciences, LLC
Guardion Health Sciences, Inc. (GHSI), already reporting to the SEC, moved up to Nasdaq Capital Market on Apr 8, 2019 with an offering at $4.00 per share raising $5M. WallachBeth Capital was lead-left underwriter, joined by WestPark. Sheppard Mullin advised the company and Carmel, Milazzo & Feil advised the underwriters.
Guardion Health Sciences, Inc. is a specialty health sciences company that develops, formulates and distributes condition-specific medical foods. Its first product, Lumega-Z, is meant to restore macular protective pigment, a risk factor for retinal diseases such as age-related macular degeneration. It also owns VectorVision Ocular Health.
- Status
- Uplisting
- Ticker
- GHSI
- Exchange
- Nasdaq Capital Market
- Listed
- Apr 8, 2019
- Price
- $4.00
- Raised
- $5M
- Market cap at IPO price
- $87.7M
- First filed
- Feb 11, 2016
- Underwriters
- WallachBeth Capital and WestPark
- Company counsel
- Sheppard Mullin
- Underwriters' counsel
- Carmel, Milazzo & Feil
- Sector
- Biotech & pharma
- Country / state
- TX
More on this listing for subscribers
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Registration statement (S-1) first filed Feb 11, 2016
- Latest amendment Mar 27, 2019
- Final prospectus (424B4) Apr 8, 2019
- All filings on EDGAR CIK 1642375
Other Biotech & pharma uplistings in 2019
- BioCardia, Inc.BCDA · Aug 5, 2019 · $10M
- Artelo Biosciences, Inc.ARTL · Jun 25, 2019 · $8M
- Chemomab Therapeutics Ltd.ANCN · Feb 13, 2019 · $30.5M